Cargando…

Exendin‐4 analogs in insulinoma theranostics

Insulinomas, neuroendocrine tumors arising from pancreatic beta cells, often show overexpression of the glucagon‐like peptide‐1 receptor. Therefore, imaging with glucagon‐like peptide analog exendin‐4 can be used for diagnosis and preoperative localization. This review presents an overview of the de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jansen, Tom.J.P., van Lith, Sanne.A.M., Boss, Marti, Brom, Maarten, Joosten, Lieke, Béhé, Martin, Buitinga, Mijke, Gotthardt, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Special Issue Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771680/ https://www.ncbi.nlm.nih.gov/pubmed/31070270 http://dx.doi.org/10.1002/jlcr.3750

Ejemplares similares

PET-Based Human Dosimetry of (68)Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging
por: Boss, Marti, et al.
Publicado: (2020)

Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
por: Boss, Marti, et al.
Publicado: (2020)

(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET
por: Brom, Maarten, et al.
Publicado: (2010)

Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging
por: Joosten, Lieke, et al.
Publicado: (2017)

Non-invasive in vivo determination of viable islet graft volume by (111)In-exendin-3
por: Eter, Wael A., et al.
Publicado: (2017)

Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
por: Boss, Marti, et al.
Publicado: (2020)

The effect of purification of Ga-68-labeled exendin on in vivo distribution
por: Brom, Maarten, et al.
Publicado: (2016)

(111)In-exendin Uptake in the Pancreas Correlates With the β-Cell Mass and Not With the α-Cell Mass
por: Brom, Maarten, et al.
Publicado: (2015)

New Radiolabeled Exendin Analogues Show Reduced Renal Retention
por: Joosten, Lieke, et al.
Publicado: (2023)

(68)Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism
por: Boss, Marti, et al.
Publicado: (2022)

Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)
por: Collado Camps, Estel, et al.
Publicado: (2022)

Detection and quantification of beta cells by PET imaging: why clinical implementation has never been closer
por: Gotthardt, Martin, et al.
Publicado: (2018)

Importance of beta cell mass for glycaemic control in people with type 1 diabetes
por: Jansen, Theodorus J. P., et al.
Publicado: (2022)

Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin
por: Willekens, Stefanie M. A., et al.
Publicado: (2016)

Whole organ and islet of Langerhans dosimetry for calculation of absorbed doses resulting from imaging with radiolabeled exendin
por: van der Kroon, Inge, et al.
Publicado: (2017)

Radiosynthesis and evaluation of an (18)F–labeled silicon containing exendin-4 peptide as a PET probe for imaging insulinoma
por: Dialer, Lukas O., et al.
Publicado: (2018)

Graft revascularization is essential for non-invasive monitoring of transplanted islets with radiolabeled exendin
por: Eter, Wael A., et al.
Publicado: (2015)

Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma
por: Kiesewetter, Dale O., et al.
Publicado: (2012)

A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelator
por: Jodal, Andreas, et al.
Publicado: (2014)

Brain Imaging of the GLP-1 Receptor in Obesity Using (68)Ga-NODAGA-Exendin-4 PET
por: Deden, Laura N., et al.
Publicado: (2021)

Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis
por: Dorst, Daphne N, et al.
Publicado: (2020)

The Role of Glucagon-Like Peptide 1 Receptor PET/CT With Ga-68-NODAGA-exendin in Localising an Insulinoma: Lessons From a Clinical Case
por: Grigoriadou, Viktoria Chatzimavridou, et al.
Publicado: (2021)

Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
por: Brom, Maarten, et al.
Publicado: (2012)

Role of Exendin-4 Functional Imaging in Diagnosis of Insulinoma: A Systematic Review
por: Sidrak, Marko Magdi Abdou, et al.
Publicado: (2023)

Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
por: Kaeppeli, Simon A. M., et al.
Publicado: (2019)

Characterization of (111)In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors
por: Willekens, Stefanie M. A., et al.
Publicado: (2018)

Photodynamic Therapy Targeting Macrophages Using IRDye700DX-Liposomes Decreases Experimental Arthritis Development
por: Dorst, Daphne N., et al.
Publicado: (2021)

Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
por: Joosten, Lieke, et al.
Publicado: (2017)

Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [(68)Ga]Ga-NODAGA-Exendin-4 Produced by a Fully Automated Method
por: Migliari, Silvia, et al.
Publicado: (2022)

PET imaging during hypoglycaemia to study adipose tissue metabolism
por: Boss, Marti, et al.
Publicado: (2019)

Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK
por: Trachsel, Belinda, et al.
Publicado: (2023)

(18)F-Labelled exendin to image GLP-1 receptor-expressing tissues: from niche to blockbuster?
por: Boerman, Otto C., et al.
Publicado: (2011)

Evaluation of (¹¹¹)In-Labelled Exendin-4 Derivatives Containing Different Meprin β-Specific Cleavable Linkers
por: Jodal, Andreas, et al.
Publicado: (2015)

SPECT-OPT multimodal imaging enables accurate evaluation of radiotracers for β-cell mass assessments
por: Eter, Wael A., et al.
Publicado: (2016)

Metastatic Insulinoma Managed with Radiolabeled Somatostatin Analog
por: Costa, Ricardo, et al.
Publicado: (2013)

(18)F-labeled PEGylated exendin-4 imaging noninvasively differentiates insulinoma from an accessory spleen: the first case report of [18F]FB(ePEG12)12-exendin-4 positron emission tomography/computed tomography for insulinoma
por: Sakaki, Kentaro, et al.
Publicado: (2023)

Ectopic insulinoma diagnosed by (68)Ga-Exendin-4 PET/CT: A case report and review of literature
por: Zhang, Xiaona, et al.
Publicado: (2021)

Distinctive detection of insulinoma using [(18)F]FB(ePEG12)12-exendin-4 PET/CT
por: Murakami, Takaaki, et al.
Publicado: (2021)

Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
por: Nock, Berthold A., et al.
Publicado: (2023)

A case of malignant insulinoma responsive to somatostatin analogs treatment
por: Caliri, Mariasmeralda, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s4rvuevtsd2249f8r37i8odvtf